The 3rd mRNA-Based Therapeutics Summit Europe, Europe's foremost gathering of mRNA experts, returns to Berlin from January 23rd at 9:00 am to January 25th at 5:00 pm. Featuring exclusive data from industry trailblazers like MHRA, EMA, BioNTech, CureVac, Ziphius Vaccines, and Moderna, the event convenes 250+ specialists across 3 days. Attendees delve into revolutionary discoveries, pre-clinical and clinical insights in mRNA therapeutic and vaccine development, fostering accelerated R&D and pipeline expansions in this groundbreaking field.

 [Read on mrnabased-therapeutics](https://mrnabased-therapeutics-europe.com/)

Embark on a pivotal journey at the Gene Therapy Regulatory Affairs Summit on January 23rd to 25th, 2024. Following FDA approvals of breakthrough gene therapies in 2023, this summit becomes a pivotal platform for regulatory experts. Witness discussions among regulatory bodies, big pharma, and innovative biotech leaders to tackle critical industry challenges. Don't miss this unique opportunity to enhance trial design, refine CMC approaches, and optimize global submission strategies. Engage with 80+ industry titans from renowned organizations, fostering invaluable insights for regulatory triumph in gene therapy development.

[Read on genetherapy](https://genetherapy-regulatory.com/)

Building on Drug Delivery 2022's success, the 22nd International Conference on Drug Delivery is set for November 17-18, 2023, in New York, USA. Renowned speakers from diverse fields, including life sciences and engineering, will share insights on peptide, gene, and drug delivery, as well as vaccines, new materials, and more. This event encourages interaction, networking, and exploration of delivery system trends and AI applications.

Read on meetingsint.com

 The "8th International Conference on Future Pharma and Innovations," scheduled for September 27-28, 2023, in Amsterdam, Netherlands, and largely focused on the theme "Pioneering the Development of Future Pharma," is cordially invited to participants from all over the world.

With its well crafted systematized scientific programme, which features interactive panel discussions, keynote lectures, grand addresses, and bill Sessions, the event provides its audience with a chic stage. The Future of Pharma R&D, Industrial Pharmacy and Physical Drugstore, Drug Discovery and Development, Novel Drug Delivery Systems, and Pharma and Biotech Financial Outlook are some of the topics covered by the global platform Future Pharma.

Read on futurepharmameetings.pharmaceuticalconferences.com

The 2nd Cell Therapy Analytical Development Summit Europe is an unmissable event for Europe's top biotech and pharma! As the cell therapy industry continues to rapidly grow and evolve, the opportunity to learn from and collaborate with leading experts in the field will ensure that potency, characterisation and multi-region access are no longer bottlenecks in the cell therapy drug development pipeline.

Read on cell-therapy-analytics-europe.com

Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE.

This decade of success has resulted in explosive investment into the development of CAR and TCR based approaches to ensure more patients around the world can benefit from these lifesaving therapies.   The 8th CAR-TCR Summit is returning to Boston as the industry's trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers. Ensure your whole team stays ahead of the curve with unmatched industry insights shared across discovery through to commercialization.  Across 3 conference days with 8 content tracks, and an additional 6 deep-dive workshops, bootcamp, focus day, diversity session, C-level think tank and more, 200+ CAR and TCR experts will lead you and over 1,000 peers in discussions that will accelerate your pipeline, bringing better drugs to patients faster.

Read on car-tcr-summit.com

Comprehensive analytical support has been crucial to the global success of mRNA medicines. As drug development timelines become more demanding, accessing novel, optimised, and high-throughput analytical methods is essential to guarantee the approval and commercialisation of safe and effective mRNA therapeutics and vaccines.

The inaugural mRNA Analytical Development Summit Europe is the only industry-dedicated forum to showcase critical expertise and the latest techniques in optimised analytics for leading European biopharma. Taking place in Berlin this August, this meeting highlights the importance of advanced analytical approaches and adherence to regulatory requirements, as the European market continues to capitalise on these strategies.

Join the main industry players as they navigate through their case studies and share their experiences!

Read on mrna-analytical-development-europe.com

Magnus Group whole heartedly welcomes you to its “International conference on Orphan Drugs and Rare Diseases” (Orphan Drugs 2023) as Online Event slated during August 17-19, 2023.  The congress deliberations will be on the theme “Orphan drugs: Ray of hope for rare disease”.

The Orphan Drug Act (ODA) of 1983 obligated manufacturers to increase the scale of orphan drugs in order to treat rare diseases and the orphan drug landscape has changed dramatically since then. Orphan medication approvals have increased in the last decade and there are over 500 candidates for orphan diseases in the pipeline. Orphan Drugs Conference provides a platform for scientists, professors, researchers, healthcare specialists, academicians, practitioners and students to discuss their latest research findings, ideas, advancements, and applications. The Rare Disease Conferences also gives a remarkable opportunity for stakeholders in the orphan drug business to meet and network with top-tier government, pharmaceutical, biotech, non-profit, orphan drug developers and research organizations. Orphan Drug Conferences 2023 putting an agenda that address the driving macroeconomic factors, policies and issue that will steer the development of orphan drugs globally including access, collaborations, policies etc.

Read on orphan-drugs.magnusconferences.com

The most anticipated event of the mRNA calendar year is back with a bang! The mRNA-Based Therapeutics Summit is returning for its 3rd year this July as the one-stop-shop for all your mRNA needs, showcasing exclusive new data from the movers and shakers in the mRNA industry. 500+ industry pioneers from the likes of the FDA, Pfizer, Moderna, BioNTech, Sanofi and many more are joining the world's only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.

Expect 100+ world-class speakers from large pharma, innovative biotechs, and key opinion leaders of academia, 5 dedicated tracks and 3 days of immersive content on discovery, translation, clinical development, chemistry, manufacturing and controls (CMC) and logistics to overcome industry hurdles of optimized dosing, targeted delivery, safety and scalability to achieve regulatory success in infectious and rare diseases, cancer and beyond!

Read on mrnabased-therapeutics.com

Drug Discovery Conferences Committee is glad to announce “25th International Conference on Drug Discovery, Design and Development” Conference during July 17-18, 2023 Tokyo, Japan. Drug Design 2023 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Drug Design 2023. Major topics includes Dug targeting & design, Drug delivery technologies, Nano technology for better drug deliverability And Novel drug delivery 

Read on drugdesign

With more than 300 trials in preclinical and clinical development actively using AAV as their vector of choice, the priority for any company working in this space is to ensure that each and every one of those therapies is the safest version it can be.

In this context, the 2nd Annual Optimizing AAV Safety Summit is returning in 2023, bringing together genetic therapy leaders across non-clinical development, clinical development, toxicology, biodistribution, and immunology who are all working to optimize the safety of their AAV-based drug products in their day-to-day.

Read on optimizing-aav-safety.com

The landscape of microbiome drug development is constantly evolving. The road to market is incredibly complex and it's vital to find the right strategic partners to bring products to patients.

Microbiome Connect: Europe is the sector's premier strategic event, enabling you to discover new innovative technologies and foster connections that will ensure your company's clinical and commercial success. Bringing together the whole microbiome therapeutics ecosystem - from investors and large pharmaceutical companies, through to the most pioneering biotechs, academic institutions and solution providers - it delivers the business-critical information you need to make strategic decisions for your organisation through in-depth case studies and expanded networking opportunities.

Read on go.evvnt.com

Welcome to the 2nd Process Development for Cell Therapies Summit: Driving Process Automation, Affordability and Scalability for Global Cell Therapies

Join 80+ experts from BMS, Janssen, ArsenalBio, Bluebird Bio, Notch Therapeutics, Bayer, and more, looking to streamline cell therapy process development by sharing best practices and pre-competitive learnings to supercharge your pipeline development.

This is your opportunity to engage with the process development for the cell therapy industry, gain insights into best practices, and progress in a pre-competitive space.

. REVIEW The Challenges, Roles and Emerging Trends in Process Development for Cell Therapies with Janssen, 2Seventy Bio and Immatics Biotechnology

. INNOVATE analytical methods and digital platforms to ensure product quality and efficacy with Arsenal Bio and Caribou Biosciences

. OPTIMIZE scalability in an automated approach to reduce human error throughout phase development with Bayer and Glycostem Therapeutics

. MINIMIZE the time of process while maximizing quality of yield with Bristol Myers Squibb and Carisma Therapeutics

. EXAMINE the technical advancements required to drive process development forward in both upstream and downstream processes with Notch Therapeutics and Tmunity Therapeutics

Join us June 20-22, 2023 in Boston, MA!

Read on process-development-celltx.com

The Molecular Pharmacology GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.

Read on grc.org

Returning for its 5th year, the Neuroimmunology Drug Development Summit is excited to bring you pioneering insights from a range of brand-new speakers across the hottest biopharma in neuroimmunology to showcase revolutionizing breakthroughs in neuroinflammatory targeting.

In 2023, you will enhance your understanding of underlying glial biology and neuroinflammatory pathways, address how to improve the development and translatability of neuroinflammatory biomarkers, and decipher the most effective in vitro and in vivo models to recapitulate all hallmarks of neuroglia.

Join 100+ neuroimmunology and neuroinflammation industry experts across numerous neurological indications to define the next steps for accelerating the translation of neuroimmunology therapeutics into the clinic.

Read on drugdevelopment.com

Are you up to date on the latest research and developments in novel biologics to enhance regenerative and precision cardiovascular therapeutics?

Don't miss the Next Generation Cardiovascular Drug Development Summit, coming to Boston on April 25-27 as the only industry-focused meeting dedicated to leveraging novel cell and gene therapies using mRNA, CRISPR/Cas9 and iPSCs for cardiovascular disease.

This inaugural summit will delve deep into the understanding of genetic components of cardiovascular disease, utilisation of imaging biomarkers, delivery of precise cardiac therapeutics, optimization of preclinical animal models, and overcoming off-target genome editing to mitigate against toxicity and long-term effects and unlock the potential of novel biologics.

With 3 days of abundant insights into the latest breakthroughs and research and a faculty of world-class speakers pioneering the next wave of novel and precise cardiovascular therapeutics, this is biopharma's unmissable meeting for the expedition of treatment for cardiovascular disease patients.

Read on cardio.com

Understand Mechanism of Action, Maximize Efficacy and Therapeutic Window, and Evaluate Long-Term Clinical Outcomes of Fc Receptor Pathway Targeting Biologics in Autoantibody Mediated Disease.

The field of FcRn receptor targeting is gaining ground-breaking speed as Argenx, Janssen, UCB and Immunovant compete to tackle myasthenia gravis and biopharma invest in transformative immunological therapy for autoimmune diseases as the next big drug opportunity.

Read on go.evvnt.com

With the recent approvals of ImmunoGen's ELAHERE, Astrazeneca and Daiichi Sankyo's DESTINY-Breast04, supporting Enhertu's use in HER2-low breast cancer as a new therapeutically targetable category, the ADC space has continued to make major waves throughout 2022, a joy to see for oncology patients around the world.

With high hopes set on Byondis for the next approval, you simply can't miss out on this highly anticipated event. Exploring all aspects of ADC development from discovery to late-stage manufacturing, this is your one-stop shop for antibody-drug conjugate content.

No ADC stone is left unturned as we unite all leading players in the field under one roof. Wherever your interest and expertise lies, we have it covered at the industry's leading conference to help forward-thinking researchers from the pharmaceutical, biotech, and academic community advance the development of antibody-drug conjugates.

Read on worldadc-europe.com

The Drug Safety Summit provides a holistic view of drug safety science, bringing together leaders in Risk Evaluation and Mitigation Strategy, Pharmacovigilance, and Regulatory Affairs to share current best practices and experiences in developing safety/regulatory strategies for different regions across the globe. With a dedicated focus on REMS and Pharmacovigilance, the Drug Safety Summit allows representatives from across drug safety teams to come together to establish practices that will limit the risks connected to their marketed products.

Read on fiercedrugsafety.com

Better cell culture media, cell lines, and bioreactor strategies are responsible for yielding 10+g/l on a consistent basis. Going forward, companies will continue to implement new technologies and process designs to support emerging therapeutics. Our experts share their personal experiences and insight to help anticipate challenges and chose appropriate technologies to support your production strategies.

Read on cii.dryfta.com

The value of real-world data is clear. The acceptance of real-world evidence (RWE) is growing. But is this enough to propel RWE from being a nice-to-have to a must-have? PicnicHealth is hosting a four-part webinar series to reframe the “ROI” for RWE generation and tackle the question: beyond the return on investment for RWE, what is the risk of inaction? This webinar will explore relevant examples of how Data Science and Digital Health are accelerating pharmaceutical innovation and driving impact for patients. Bringing together global experts with diverse perspectives spanning regulatory, R&D and health tech, this conversation will highlight innovative, RWD-driven approaches to drug development and regulatory decision-making. Speakers will discuss the need for different types of data to construct a complete clinical picture – and how a data-driven approach can drive impact across both research and clinical practice. Register today to learn more about the transformational value of real-world data for drug development and regulatory decision-making.

Read on xtalks.com

The value of real-world data is clear. The acceptance of real-world evidence (RWE) is growing. But is this enough to propel RWE from being a nice-to-have to a must-have? PicnicHealth is hosting a four-part webinar series to reframe the “ROI” for RWE generation and tackle the question: beyond the return on investment for RWE, what is the risk of inaction? This webinar will explore relevant examples of how Data Science and Digital Health are accelerating pharmaceutical innovation and driving impact for patients. Bringing together global experts with diverse perspectives spanning regulatory, R&D and health tech, this conversation will highlight innovative, RWD-driven approaches to drug development and regulatory decision-making. Speakers will discuss the need for different types of data to construct a complete clinical picture – and how a data-driven approach can drive impact across both research and clinical practice. Register today to learn more about the transformational value of real-world data for drug development and regulatory decision-making.

Read on xtalks.com

Exploit Understanding of TGF-β Biology, Harness Clinically Validated Biomarkers & Advance Safe & Efficacious Clinical Programs for Maximal Therapeutics Benefit in Immuno-Oncology.

In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine.

From uncovering the effects and production of TGF-β in immune, tumor and stromal cells to exploring predictive and pharmacodynamic TGF-β biomarkers for patient identification and assessing the clinical challenges that led to recent clinical failures, the 3rd TGF-β for Immuno-Oncology Drug Development Summit is your one-stop-shop dedicated to harnessing you with the knowledge to unlock the potential of successfully targeting TGF-β.

Tailored with 18+ senior leaders, the 2023 meeting will be taking place in-person for the first time - don't miss your chance to be in the room for your comprehensive guide on TGF-β in immuno-oncology!

Whether you are new to this field or a seasoned expert, this meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.

Read on summit.com

With 10 million people worldwide living with IBD, there is an urgent need to move away from a one-size-fits-all standard of care and invest in the use of precision medicine to make informed decisions through patient selection and clinical monitoring, to reduce cost of care, prevent relapses and achieve long term remission.

Uniting experts across pharma, biotech and academia, the Precision Medicine in Inflammatory Bowel Disease Summit is your only dedicated forum to benchmark novel markers and innovative technology across RNA-sequencing, metabolomics, proteomics and more. Be involved in this cross-indication collaboration to translate basic immunology into clinical response and develop your biomarker strategy early.

Developed in collaboration with key industry thought leaders from AbbVie, Celsius Therapeutics, Crohn's and Colitis Foundation, Janssen, Prometheus Bioscience and more, leave this meeting with key lessons learned to improve your clinical trial efficacy, and patient care for those suffering with IBD.

Read on go.evvnt.com